The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.

“Trump ’47 should not allow Trump ’45’s massive public health achievement to be cancelled — especially when that legacy will ...